tedisamil has been researched along with Atrial Fibrillation in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conway, E; Kowey, PR; Musco, S | 1 |
| Krishnamoorthy, S; Lip, GY | 1 |
| Papp, JG; Singh, BN | 1 |
| Dorian, P | 1 |
| Opie, LH | 1 |
| Singh, S | 1 |
| Beckmann, K; Dorian, P; Hohnloser, SH; Kowey, P; Straub, M | 1 |
| Banchs, JE; Gonzalez, MD; Naccarelli, GV; Penny-Peterson, E; Samii, S; Wolbrette, DL | 1 |
| Camm, J; Savelieva, I | 1 |
| Barrett, TD; Fischbach, PS; Goyal, R; Hennan, JK; Lucchesi, BR; Syed, ZA; Tran, BC | 1 |
| Bianconi, L; Castro, A; Santini, M | 1 |
8 review(s) available for tedisamil and Atrial Fibrillation
| Article | Year |
|---|---|
New horizons in antiarrhythmic therapy: will novel agents overcome current deficits?
Topics: Amiodarone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anisoles; Anti-Arrhythmia Agents; Anticoagulants; Atrial Fibrillation; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Cyclopropanes; Dronedarone; Humans; Hydantoins; Imidazolidines; Piperazines; Pyrrolidines | 2008 |
Novel antiarrhythmic drugs in atrial fibrillation: focus on tedisamil.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Cyclopropanes; Dose-Response Relationship, Drug; Humans; Molecular Structure | 2009 |
Antiarrhythmic drug therapy of atrial fibrillation: focus on new agents.
Topics: Action Potentials; Anti-Arrhythmia Agents; Atrial Fibrillation; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Electrophysiology; Humans; Potassium Channels | 2003 |
Tedisamil in coronary disease: additional benefits in the therapy of atrial fibrillation?
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Bridged Bicyclo Compounds, Heterocyclic; Coronary Artery Disease; Cyclopropanes; Electrophysiology; Humans; Oxygen; Sinus of Valsalva | 2003 |
Trials of new antiarrhythmic drugs for maintenance of sinus rhythm in patients with atrial fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Cyclopropanes; Dronedarone; Humans; Hydantoins; Imidazoles; Imidazolidines; Indoles; Oxazines; Phenethylamines; Piperazines; Serotonin 5-HT4 Receptor Antagonists; Sulfonamides | 2004 |
New antiarrhythmic treatment of atrial fibrillation.
Topics: Adenosine; Adenosine A1 Receptor Antagonists; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Benzofurans; Biphenyl Compounds; Bridged Bicyclo Compounds, Heterocyclic; Carbazoles; Carvedilol; Cyclopropanes; Dronedarone; Fatty Acids, Omega-3; Furans; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Oligopeptides; Organic Chemicals; Peptidyl-Dipeptidase A; Potassium Channel Blockers; Propanolamines; Purinergic P1 Receptor Agonists | 2007 |
Update on atrial fibrillation: part II.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Humans; Hydantoins; Imidazolidines; Piperazines; Pulmonary Veins | 2008 |
New antiarrhythmic drugs for the treatment of atrial fibrillation.
Topics: Aminobenzoates; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Dronedarone; Humans; Hydantoins; Imidazoles; Imidazolidines; Phenethylamines; Piperazines; Sotalol; Sulfonamides | 2002 |
1 trial(s) available for tedisamil and Atrial Fibrillation
| Article | Year |
|---|---|
Safety and efficacy of intravenously administered tedisamil for rapid conversion of recent-onset atrial fibrillation or atrial flutter.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Flutter; Bridged Bicyclo Compounds, Heterocyclic; Combined Modality Therapy; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Electric Countershock; Electrocardiography; Endpoint Determination; Female; Heart Conduction System; Humans; Injections, Intravenous; Male; Middle Aged; Survival Analysis; Treatment Outcome | 2004 |
2 other study(ies) available for tedisamil and Atrial Fibrillation
| Article | Year |
|---|---|
Atrial fibrillation: emerging possibilities for drug treatment: an overview of current opportunities and recent developments.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Bridged Bicyclo Compounds, Heterocyclic; Clinical Trials as Topic; Cyclopropanes; Humans; Prognosis | 2003 |
Conversion of atrial fibrillation by the experimental antiarrhythmic drug tedisamil in two canine models.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Cyclopropanes; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Michigan; Models, Cardiovascular; Reaction Time | 2001 |